The Spectrum of Pulmonary Toxicity in Pancreatic Cancer Patients Receiving Gemcitabine Combination Chemotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
The Spectrum of Pulmonary Toxicity in Pancreatic Cancer Patients Receiving Gemcitabine Combination Chemotherapy ; volume:12 ; number:2 ; year:2019 ; pages:506-512
Case reports in oncology ; 12, Heft 2 (2019), 506-512
- Urheber
-
Baig, Jalal
Shokouh-Amiri, Mohammad
Chan, Juliana
Chowdhery, Rozina
Danthurthy, Samaya
Venepalli, Neeta K.
- DOI
-
10.1159/000500242
- URN
-
urn:nbn:de:101:1-2019091200202622585447
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Baig, Jalal
- Shokouh-Amiri, Mohammad
- Chan, Juliana
- Chowdhery, Rozina
- Danthurthy, Samaya
- Venepalli, Neeta K.
Ähnliche Objekte (12)
Gemcitabine-Induced Cardiotoxicity in Patients Receiving Adjuvant Chemotherapy for Pancreatic Cancer: A Case Series
Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapy
Impact of liver fibrosis on survival of patients with intrahepatic cholangiocarcinoma receiving gemcitabine-based chemotherapy
Fatal gemcitabine-induced pulmonary toxicity in metastatic gallbladder adenocarcinoma
Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy
Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison
Control of chemotherapy-induced nausea in patients receiving outpatient cancer chemotherapy
Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer
Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy
ASSESSMENT OF NUTRITIONAL STATUS OF PATIENTS RECEIVING CHEMOTHERAPY
Gemcitabine–cisplatin versus MVAC chemotherapy for urothelial carcinoma: a nationwide cohort study
Gemcitabine as chemotherapy of head and neck cancer in Fanconi anemia patients
Gemcitabine-Induced Cardiotoxicity in Patients Receiving Adjuvant Chemotherapy for Pancreatic Cancer: A Case Series
Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapy
Impact of liver fibrosis on survival of patients with intrahepatic cholangiocarcinoma receiving gemcitabine-based chemotherapy
Fatal gemcitabine-induced pulmonary toxicity in metastatic gallbladder adenocarcinoma
Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy
Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison
Control of chemotherapy-induced nausea in patients receiving outpatient cancer chemotherapy
Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer
Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy
ASSESSMENT OF NUTRITIONAL STATUS OF PATIENTS RECEIVING CHEMOTHERAPY
Gemcitabine–cisplatin versus MVAC chemotherapy for urothelial carcinoma: a nationwide cohort study
Gemcitabine as chemotherapy of head and neck cancer in Fanconi anemia patients
Gemcitabine-Induced Cardiotoxicity in Patients Receiving Adjuvant Chemotherapy for Pancreatic Cancer: A Case Series
Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapy
Impact of liver fibrosis on survival of patients with intrahepatic cholangiocarcinoma receiving gemcitabine-based chemotherapy
Fatal gemcitabine-induced pulmonary toxicity in metastatic gallbladder adenocarcinoma
Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy
Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison
Control of chemotherapy-induced nausea in patients receiving outpatient cancer chemotherapy
Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer
Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy
ASSESSMENT OF NUTRITIONAL STATUS OF PATIENTS RECEIVING CHEMOTHERAPY
Gemcitabine–cisplatin versus MVAC chemotherapy for urothelial carcinoma: a nationwide cohort study